SUMMARY Eighteen cases of Cushing's syndrome caused by ectopic production of peptide hormones were investigated by histological and immunocytochemical methods and the findings correlated with clinical and biochemical observations. Immunocytochemistry showed immunoreactive adrenocorticotrophic hormone (ACTH) or peptides derived from the ACTH precursor (pro-opiomelanocortin (POMC)), or both, in a total of 10 cases: five of these also contained immunoreactive-a-melanocyte stimulating hormone, indicating more extensive translational processing of POMC than normally occurs in healthy corticotrophs of the anterior pituitary; in two further cases peptides capable of stimulating ACTH release from the anterior pituitary were present. In the remaining six cases immunocytochemistry failed to show the presence of ACTH, other POMC derived peptides, or peptides with ACTH releasing properties. These findings correlate well with the histological and clinical observations, in that the six tumours had been clinically overt, caused rapid death, and histologically seemed to be highly malignant. In contrast, the 12 other tumours were occult to radiological examination, patients had a much improved survival rate, and histologically the tumours seemed to be less aggressive. All but one of the tumours in this series showed a degree of neuroendocrine differentiation, indicated by the presence of neuron specific enolase.
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These results suggest that one feature of highly malignant tumours, which cause an ectopic endocrine syndrome, is a high secretion of peptide hormones, leaving amounts that are too small to be shown by immunocytochemistry.
Howlett et al recently reviewed all the cases of Cushing's syndrome caused by hypersecretion of adrenocorticotrophic hormone (ACTH) investigated in the department of endocrinology at this hospital between 1969 and 1985.' Of 71 patients, 16 cases resulted from secretion of ACTH from an ectopic site. They were able to divide patients into two groups on the basis of clinical observations at the time of presentation. Group 1 patients (n = 6) had obvious signs of an underlying tumour, while those in group 2 (n = 10) had tumours that were occult to radiological examination, and extensive investigation was required for their localisation.' We now report the histological and immunocytochemical features of these 16 tumours and of two additional cases in which the tumours were also clinically occult. We were particularly interested to note any correlation between the histological tumour type, the range of peptides Accepted for publication 8 April 1986 that could be shown in tumour cells, and the clinical and biochemical findings. Material and methods purified, peroxidase labelled, donkey antirabbit IgG (Guildhay Antisera, Guildford, United Kingdom) Tissues from 17 cases were removed during surgery or was applied diluted 1/300 for 30 minutes at room temat necropsies performed on patients diagnosed and perature and immunoreactive sites shown by polymanaged in our unit. Sixteen patients had suffered merisation of diaminobenzidine tetrahydrochloride from ectopic ACTH production,1 while the other (DAB) (Sigma Chemicals, Dorset, United Kingdom). patient had been previously reported as a case of
Immunostaining controls included staining of ectopic bombesin production causing excessive pitu-known positive tissues (table 1) and replacement of Tumours that cause ectopic Cushing's syndrome primary antisera by serum from a non-immunised rabbit. The staining patterns of each antiserum were observed both in normal and neoplastic tissues and seemed to be specific for the given antigen. The peptide hormone antisera had been characterised for use in radioimmunoassay and in many instances tested by liquid phase absorption with the synthetic peptide. In two cases no further material was available: table 2 includes the original findings.
Immunostained sections were assessed independently by two observers (PJC and ID) and results were partially quantified on a scale of 0 to 3 on the basis of the percentage of cells staining positively.
Patients were divided into the same two groups mentioned previously, purely on the basis of clinical observations at the time of presentation. Table 2 gives the details of clinical and histological observations. Group 1 tumours consisted of three small cell carcinomas of the lung, one atypical carcinoid of the gall bladder, one pancreatic endocrine tumour, and one undifferentiated carcinoma of the colon. Each of these tumours was highly malignant and all had metastasised. All patients died within eight months of presentation. More slow growing, relatively benign carcinoid tumours predominated in group 2 patients, comprising six lung carcinoids and two thymic carcinoids. One pancreatic endocrine tumour, one medullary carcinoma of the thyroid, and two phaeochromocytomas were also present. Histologically, these tumours seemed to be far less agressive than those of group 1. Three patients in group 2 have subsequently died, but only after a period of time from between 3 12and 10 /2years following diagnosis. Other regulatory peptides were also more commonly seen in group 2 tumours than in those of group 957 1. Thus immunoreactive bombesin was seen in a total of seven cases, all belonging to group 2. Immunoreactive calcitonin was found in five group 2 tumours but in none of the tumours of group 1. Immunoreactive human chorionic gonadotrophin was seen in a total of seven cases, six belonging to group 2. Each of the six group 2 tumours contained only the a subunit, while in the single positive group I tumour both a and / subunits were detected. Somatostatin was present in one case from each group. Neuron specific enolase immunostaining was positive in all but the one case of an undifferentiated carcinoma of the colon included in group 1.
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The association between Cushing's syndrome and tumours of "non-endocrine" organs dates back to 1928.6 Since then the presence and secretion of ACTH by such tumours has repeatedly been shown.78 A wide variety of tumours may cause Cushing's syndrome, most of these tumours being derived from cells of the diffuse neuroendocrine system (formerly APUD),9 10 so that the term "nonendocrine" is no longer considered to be appropriate for most tumours. The term "ectopic" was introduced to describe the production by neoplastic tissues of hormones that are not produced normally by the tissue of origin.11 It must always be borne in mind, however, that a wide variety of tissues synthesise peptide hormones, including ACTH, under normal conditions, so that hormone elaboration by a tumour may not be "ectopic" in the strictest sense of the word.
"Ectopic" hormone production is said to account for between 12 and 25% of cases of Cushing's syndrome, and small cell carcinomas are the most commonly recognised tumour.13 These tumours produce symptoms quite unlike those of classical Cushing's syndrome, caused mainly by the effects of a rapidly growing highly malignant tumour. The presence of a relatively small, more benign tumour secreting ACTH, however, typically a lung carcinoid, will produce clinical features that mimic pituitary ACTH dependent Cushing's disease more closely.14 In this series such tumours accounted for 10 of 18 cases, with two further occult tumours secreting peptides with ACTH releasing activity, while only three cases were small cell carcinomas of the lung.
These findings contrast sharply with those of previous reports,8-10 13 and are probably attributable to the development of more thorough and precise investigative procedures'-and possibly the selective influence of--a specialised unit towards the more difficult differential diagnosis of Cushing's syndrome. Immunocytochemical investigation of our cases by tumour cells. Such a hypothesis is unlikely, as it pinpointed several interesting aspects. First, there is has been shown that POMC peptides are secreted the one case that was negative when immunostained concomitantly by both pituitary adenomas and for neuron specific enolase. This case was that of an ectopic ACTH producing tumours.17 A more plauundifferentiated carcinoma of the colon and seems to sible explanation is the presence of larger molecular have been genuinely responsible for the observed clin-weight precursor forms, which are not immunoical syndrome, as no other cause could be found at reactive to our particular anti-ACTH serum, caused necropsy. Moreover, the rapid onset of the patient's by different structural arrangements of the peptide illness and the exaggeratedly high concentrations sequences. Similar conclusions were drawn from an of plasma ACTH (2340 ng/l) found by radio-immunocytochemical study of the reactivities seen in immunoassay are not in keeping with a smaller, slow glucagonomas using antisera to glucagon and other growing tumour, which might possibly have escaped portions of its precursor.18 The presence of immudetection, nor with pituitary dependent Cushing's dis-noreactive a-melanocyte stimulating hormone in five ease. The association between Cushing's syndrome cases is indicative of more extensive processing of and tumours that do not display neuroendocrine POMC than normally occurs in normal pituitary corcharacteristics seems to be rare but genuine and has ticotrophs and which is seen in corticotroph adenoma been reported for carcinoma of the colon.'5 16 In causing Cushing's disease. '9 spite of this neuron specific enolase immunostaining
Immunoreactive CRF-41 was found in one case of was still the most reliable diagnostic aid in this study. phaechromocytoma, and presumably accounts for We were able to show the presence of POMC this patient's Cushing's syndrome. The structure of derived peptides in a total of 10 cases, although CRF-41 has only recently been determined,20 so that Tumours that cause ectopic Cushing's syndrome The correlation between immunocytochemical results and clinical observations was remarkably good. The patients had been divided into two groups, purely on the basis of overt or occult tumours at the time of presentation, and it is not surprising that this correlated with the nature of the tumours. Thus rapidly growing tumours with widespread metastases were found in group I patients, while group 2 tumours were smaller, slower growing, and less aggressive in nature. We found that cells of highly malignant tumours causing Cushing's syndrome did not contain sufficient hormone for immunocytochemical confirmation. In a similar study to ours24 it was likewise found that neither immunoreactive ACTH nor immunoreactive fi-endorphin could be shown in two of eight cases of ectopic Cushing's syndrome. Those two cases were malignant tumours, with widespread metastases present at surgery. One other case was diagnosed as malignant, and immunoreactive ACTH cells were only sparsely present. From the details given, it seems the remaining five cases in this report showed clinical and survival features in common with our group 2 patients, and positive immunostaining was found in all five cases.
One possible explanation for the negative immunocytochemical reactions in our group of six highly malignant tumours is heterogeneity of cells-that is, the areas we examined happened to be devoid of positive cells. We feel this to be unlikely, especially as we examined more than one area, including metasases, in three cases, and multiple sections were stained in all cases. A more feasible explanation for our results is that cells of these tumours rapidly secreted ACTH, with concomitant secretion of precursor fragments, leaving insufficient amounts stored that could be shown by our technique. This proposal is in keeping with the low concentration of ACTH found in extracts of malignant ectopic Cushing's tumours,'0 even though these patients suffer from excessively 960 high plasma ACTH.' The paucity of other regulatory peptides seen in these tumour cells may likewise be due to rapid secretion. We therefore concl-dde that one feature of highly malignant endocrine tumours is an excessively high secretion rate leading to low storage concentrations of peptide hormones. 
